These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10864134)

  • 21. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development.
    Kömhoff M; Wang JL; Cheng HF; Langenbach R; McKanna JA; Harris RC; Breyer MD
    Kidney Int; 2000 Feb; 57(2):414-22. PubMed ID: 10652018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes.
    Knock GA; Aaronson PI
    Br J Pharmacol; 1999 Jul; 127(6):1470-8. PubMed ID: 10455298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of nimesulide on constitutive and inducible cyclooxygenases.
    Tavares IA; Bishai PM; Bennett A
    Arzneimittelforschung; 1995 Oct; 45(10):1093-5. PubMed ID: 8595066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.
    Julémont F; de Leval X; Michaux C; Damas J; Charlier C; Durant F; Pirotte B; Dogné JM
    J Med Chem; 2002 Nov; 45(23):5182-5. PubMed ID: 12408728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
    J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide.
    Wober W
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():33-8. PubMed ID: 10369404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human and rat cyclooxygenases are pharmacologically distinct.
    Ramesha CS
    Adv Exp Med Biol; 1997; 407():67-71. PubMed ID: 9321933
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity.
    Vago T; Bevilacqua M; Norbiato G
    Arzneimittelforschung; 1995 Oct; 45(10):1096-8. PubMed ID: 8595067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective cyclooxygenase-2 inhibition by nimesulide in man.
    Cullen L; Kelly L; Connor SO; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nimesulide analogues: From anti-inflammatory to antitumor agents.
    Catarro M; Serrano JL; Ramos SS; Silvestre S; Almeida P
    Bioorg Chem; 2019 Jul; 88():102966. PubMed ID: 31075744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of nimesulide.
    Bennett A
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():1-3. PubMed ID: 10369398
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
    Steiner AA; Li S; Llanos-Q J; Blatteis CM
    Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular model of the interaction between nimesulide and human cyclooxygenase-2.
    García-Nieto R; Pérez C; Checa A; Gago F
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():14-8. PubMed ID: 10369401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
    Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
    Giuliano F; Warner TD
    Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nimesulide and indomethacin on contractility and the Ca2+ channel current in myometrial smooth muscle from pregnant women.
    Sawdy R; Knock GA; Bennett PR; Poston L; Aaronson PI
    Br J Pharmacol; 1998 Nov; 125(6):1212-7. PubMed ID: 9863649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states.
    Ward A; Brogden RN
    Drugs; 1988 Dec; 36(6):732-53. PubMed ID: 3065059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.